Raising $5M in Series A Round for Commercialization and Sales
100 M stroke survivors globalally needing hand rehabilitation.
Current Standard-of-Care focusses on balance, gait and Speech
No effective Intervention for Hand = Life Long disability.
Costs ~$46 billion/Year to the US Economy
The MyHandTM System
Digital Neuro-Rehab Platform for Home or Clinic use
Large and poorly met market.
With a mission to help 100 million stroke survivors living with hand function disability. IRegained has developed the MyHand™ System – a neuroplasticity enhancing, research-driven, telemedicine-powered, clinically effective and affordable hand function rehabilitation system.
Consistent and repeated results from 3 independent studies conducted from 2021-2023
Key Highlights
Healthcare, science and engineering, technology, platforms, therapy, telehealth, software, medical devices, rehabilitation, stroke/neurology, musculoskeletal, neuroplasticity, telemedicine
Phase I: Rehabilitation Hospitals, Clinics, Nursing Homes, Skilled Nursing Facilities (SNFs), Long-term Care Centers and Individual PTs/OTs
Phase II: Home Healthcare Agencies and Individual Stroke Patients for Home-Use
In 70%, of stroke survivors, the brain damage from stroke results in impaired hand function. This makes mundane tasks, such as holding a cup, combing hair or toileting almost impossible to do.
Many stroke survivors have to live with this disability for rest of their lives, often times with the help of personal support workers and caregivers.
This can lead to a reduce overall quality of life for the patient, it also costs the US healthcare system $34 billion annually, without taking into account the lost workdays and ultimetly, the reduced economic output.
Beyond Stroke, hand function loss can happen from other conditions suc as, traumatic brain injury, musculoskeletal injury, war, industrial accidents or sports related injuries, in many cases leading to life-long disability and a very poor quality of life.
Recovering hand function requires targeted neuro-rehabilitation therapy with intensity and repetition for months and potentially years (10-20 sessions per week).
Furthermore, there are very few clinically validated hand-function rehabilitation devices in the market.
Those that exist are either ineffective (ex: squeeze balls, rubber bands, etc.) because they do not leverage neuroplasticity to recover control the hand, or cost prohibitive (e.g. robotic devices >$150,000) and therefore unaffordable.
The system leverages neuroplasticity, the human brain’s ability to ‘reprogram’ its neural pathways. Backed by 40 years of clinical and scientific research-based evidence and with guidance from accomplished rehab professionals, this system can help people with hand-function disability regain their independence.
The MyHand™ System is:
Intelligent
Smart device built on intelligent and unique clinical protocols for targeted hand therapy.
Connected
IoMT-based internet-connected device with built-in IRegained app store to access engaging hand-rehab games.
Neuroplastic
Intelligent algorithms developed through deep scientific research on leveraging neuroplasticity and applying it for motor control recovery.
Built for Tele-Rehab
Integral telemedicine platform for remote rehabilitation in the comfort of patient’s home.
Effective
Demonstrated clinical efficacy in recovery of hand function.
Affordable
Affordable system with attractive financing and leasing options.
We offer a compelling value proposition for customers across the full continuum of rehabilitation care in all settings. There is 4-5 month pay back period and strong ROI for clinics, rehab hospitals and long term-care institutions. We also have other models like Lease, Financing and HaaS available to rehabilitation centers and service providers for rapidly adopting this superior technology and demonsrating better value and outcoms for their patients.
Further, COVID-19 has set a trend for expansion of remote rehabilitation and monitoring market, and IRegained's MyHand™ System was designed to cater with this setting.
MyHand™ System is already FDA registered under Class I (lower regulatory barrier = faster market development) and patent protected in US and China and patents pending in the EU, Canada and India (Strong IP = higher competitive barrier).
OUR TREMENDOUS ACHIEVEMENTS SINCE SEED FUNDING
Octane Launchpad Alumni, Irvine, CA, USA -- Accelerator
SoCal Bio, CA, USA – Incubator
Canadian Technology Accelerator (CTA Graduate) – Accelerator Program
University City Science Center & Launch Lane Accelerator, Philadelphia, PA, USA – Accelerator
Ionic Mechatronics, Sudbury, ON, Canada – Hardware Development Partner
Synaptic Technologies, Sudbury, ON, Canada – Software Development Partner
NORCAT, Sudbury, ON, Canada -- Incubator
Foundry, Innovation Centre at Laurentian University, Sudbury, ON, Canada - Incubator
Laurentian University, Sudbury, ON, Canada – Academic Research Partner
Cambrian College, Sudbury, ON, Canada -– Academic Research Partner
Health Sciences North and HSNRI, Sudbury, ON, Canada – Clinical Research Partner
Baycrest Hospital, Toronto, ON, Canada
McMaster University, Sudbury, ON, Canada - – Clinical Research Partner
Sunnybrook Hospital, Toronto, ON, Canada -- – Clinical Research Partner
Sheba Medical Center, Tel Aviv, Israel - – Clinical Research Partner
University of Texas, San Antonio, Texas, USA - – Clinical Research Partner
Christian Medical College & Hospital (CMC&H), Vellore, TN, India - Academic & Clinical Research Partner
Cerner India Pvt. Ltd., Bangalore, India – Advanced Technology Development & R&D Partner
Taipei Medical University, Taipei, Taiwan - Clinical Research Partner
Apollo Hospitals, Hyderabad, India - Clinical Research Partner
i2i, Taipei, Taiwan - Incubator and Industry Partner
BE Accelerator, Taipei, Taiwan - Incubator
Wistron, Taipei, Taiwan - APAC Strategic Distribution Partner
Northern Ontario School of Medicine, Sudbury, ON, Canada - Academic & Clinical Research Partner
TMU Biomed Accelerator, Taipei, Taiwan - Incubator
Tel Aviv Univeristy, Tel Aviv, Israel - Academic Research Partner
University of Texas Health Sciences Center, San Antonio, TX, USA - Academic Research Partner
OUR ADVISOR
Dr. Jocelyn Harris (Chair, CAB)
Associate Professor, McMaster University
Dr. Julie Vaughan Graham
Physical Therapist, Adjunct Lecturer, University of Toronto.
Dr. Yafi Levanon
Occupational Therapist, Tel Aviv University, Sheba Medical Centre, Israel
Dr. Jed Meltzer
Neuroscientist, Baycrest Hospital, University of Toronto
Dr. Shoba Moses
Clinical Occupational Therapist, Dallas, USA
Dr. Michael Franklyn
Prof. Northern Ontario School of Medicine
Peter Dal Bianco
Sudbury, ON Canada
Neelima Firth
Thousand Oaks, CA, USA
David Hood
Long Beach, CA, USA
Rav Sheth
Boston, MA USA
Chad Pallopson
Toronto, ON Canada
Dr. Dennis Reich
Sudbury, ON Canada
JOIN US ON THIS AMAZING JOURNEY
Our Series A Round is currently open. Contact us to learn more.
For this round, IRegained is seeking a total raise of USD $5,000,000 /CAD $ 8,000,000 to deploy resources for marketing, sales, product manufacturing and comemrcialization activities.
The funds will allow us to reach the following milestones:
Manufacture our FDA Registered, commercial MyHand™ System
Launch and distribute our MyHand™ System to all our customer leads and develop new customers through various early adopter and Loan-to-Own Programs
Hire key resources to market and sell the product in USA and Canada
IRegained is on a mission to help 100 million stroke survivors regain their hand function.
We are strategically poised to serve a large, poorly met market that has yet to find the solution they needed by stroke patients to live a healthier, more functional life.
We have achieved significant milestones, despite odds and challenges from COVID-19.
And with your financial support, we can do so much more.
For more information on this investment opportunity, please contact:
Vineet Johnson, CEO
Standing united in our dreams to help stroke patients reclaim their lives.
IRegained Inc. is a MedTech company developing novel solutions for the physical rehabilitation needs of people with disabilities. With a mission to help 100 million stroke survivors who have hand function impairment, IRegained has developed the MyHand™ System.
NORCAT, 1545 Maley Drive, Sudbury, ON, P3A 4R7
